Of note, there is evidence that the etiology of inflammatory bowel disease is associated with the pathogenetic interaction between the perturbation of GM diversity and the impact of IDO activity on the permeability of the intestinal barrier (96). This evidence concerns the gene IDO1 and inflammatory bowel disease.